To investigate the risk factors for urination disorders in patients with Guillain-Barre syndrome (GBS) and the incidence of urination disorders in child patients. Methods: We systematically retrieved literature published in PubMed and CNKI up to December 23, 2019 related to urination disorders in GBS patients. The quality of the study was assessed by Agency for Healthcare Research and Quality (AHRQ) guidelines for cross-sectional studies. Meta-analysis was performed by R3.6.3 software, and the combined effect size included the odds ratio (OR) and 95% confidence interval (CI). Results: A total of 15 studies were included. There were 6 studies with our desired outcome indicator. The results showed there was no significant difference in EMG type (OR=1.07, 95%CI=0.61-1.89, P=0.81) and cerebral nerve involvement (OR=1.73, 95%CI= 0.38-7.85, P=0.48) between patients with urination disorders and without. However, there was a statistically significant difference in Hughes score (OR=0.23, 95%CI=0.11-0.50, P=0.00) between the two groups. Nine studies were included in the meta-analysis of incidence of urination disorders in child patients, and the results showed a 10.5% incidence (95% CI=0.05-0.16). Conclusion: A high Hughes score was a risk factor for urination disorders in patients with GBS, and the incidence of urination disorders in child patients was 10.5%.